Accu-View Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 17-07-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 4.60 M
as on 17-07-2024
- Satisfied Charges ₹ 10.20 Cr
as on 17-07-2024
- Revenue -90.62%
(FY 2017)
- Profit -182.55%
(FY 2017)
- Ebitda -108.73%
(FY 2017)
- Net Worth -79.35%
(FY 2017)
- Total Assets -14.34%
(FY 2017)
About Accu-View Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹4.60 M. The company has closed loans amounting to ₹10.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Gupta and Aradhana Gupta serve as directors at the Company.
- CIN/LLPIN
U85110GJ2011PTC067440
- Company No.
067440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2011
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Accu-View Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aradhana Gupta  | Director | 12-Oct-2011 | Current |
| Amit Gupta | Director | 12-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Accu-View Diagnostics.
Accu-View Diagnostics Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 90.62% decrease. The company also saw a substantial fall in profitability, with a 182.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accu-View Diagnostics?
In 2017, Accu-View Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Airmed Pathology Private LimitedActive 8 years 4 monthsAmit Gupta and Aradhana Gupta are mutual person
- Unohealthtech Private LimitedActive 2 years 2 months
Amit Gupta and Aradhana Gupta are mutual person
- Pixel Pathlabs Private LimitedActive 10 years 4 months
Amit Gupta and Aradhana Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Sep 2017 | ₹4.60 M | Open |
Nutan Nagarik Sahakari Bank Ltd Creation Date: 24 Sep 2014 | ₹4.00 M | Satisfied |
Ge Capital Services India Creation Date: 28 Sep 2012 | ₹3.01 Cr | Satisfied |
How Many Employees Work at Accu-View Diagnostics?
Accu-View Diagnostics has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accu-View Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accu-View Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
